Cite
Disposition of 5-aminosalicylic acid by olsalazine and three mesalazine preparations in patients with ulcerative colitis: comparison of intraluminal colonic concentrations, serum values, and urinary excretion
MLA
Laursen, L.Staerk, et al. “Disposition of 5-Aminosalicylic Acid by Olsalazine and Three Mesalazine Preparations in Patients with Ulcerative Colitis: Comparison of Intraluminal Colonic Concentrations, Serum Values, and Urinary Excretion.” Gut, vol. 31, no. 11, Nov. 1990, p. 1271. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.9212720&authtype=sso&custid=ns315887.
APA
Laursen, L. S., Stokholm, M., Bukhave, K., Rask-Madsen, J., & Lauritsen, K. (1990). Disposition of 5-aminosalicylic acid by olsalazine and three mesalazine preparations in patients with ulcerative colitis: comparison of intraluminal colonic concentrations, serum values, and urinary excretion. Gut, 31(11), 1271.
Chicago
Laursen, L. Staerk, M. Stokholm, K. Bukhave, J. Rask-Madsen, and K. Lauritsen. 1990. “Disposition of 5-Aminosalicylic Acid by Olsalazine and Three Mesalazine Preparations in Patients with Ulcerative Colitis: Comparison of Intraluminal Colonic Concentrations, Serum Values, and Urinary Excretion.” Gut 31 (11): 1271. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.9212720&authtype=sso&custid=ns315887.